Our Leadership Team
|
Susan Pederson, ACA
Chief Accounting Officer Susan brings to the team over 40 years of operational experience. As Renexxion’s Chief Accounting Officer, Susan oversees finance and accounting, in addition to supporting legal, human resources and communication activities.
Prior to joining Renexxion, Susan was Vice President of Finance and Accounting at IL-2Rx, Inc. Susan previously held VP of Finance and Accounting and Financial Controller roles at Life Science companies including Imago BioSciences, Inc, IL-2Rx, Inc, Ignite Immunotherapy, Inc, Veracyte and CareDx, Inc. She was an integral Finance Team member at the following: Imago BioSciences, Inc which went IPO in July 2021 and was just purchased by Merck & Co in Nov 2022, and Ignite Immunotherapy which Pfizer purchased in Oct, 2019. Susan began her career at Greenstein & Company, CPA in Palo Alto, CA in 1984. She went on to establish her career in Finance at various California companies. She has a Bachelor of Science degree from Golden Gate University in Accounting. |